University of Massachusetts, Boston
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Boston sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
University of Massachusetts, Boston: 18 sponsored US clinical trials, 4 recruiting.
University of Massachusetts, Boston sponsors 18 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 14 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 2 trials.
Top-decile sponsor footprint
University of Massachusetts, Boston ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
18 total, page 1 of 1
Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
NCT06554340
Kidney Blood Flow During Exercise in Older African American Adults
NCT07029165
Neural Control of Kidney Blood Flow During Exercise in African American Adults
NCT03981640
Sex Effects on Blood Pressure With Handgrip Training
NCT06215014
Teaching the Social Determinants of Health to Nursing Students With Simulation
NCT05685082
Forms of Racial Discrimination Study
NCT03720600
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
NCT03289676
Smoking Cessation Intervention for Women Living With HIV
NCT02898597
Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults
NCT03086772
Transmission of Mother-Infant Stress Communication
NCT02013401
Soy Supplementation and Gestational Diabetes
NCT02806739
A Family-Based Weight Loss Intervention for Youth With Intellectual Disability
NCT02033642
Measuring Quality of Decisions About Treatment of Depression
NCT01152307
Measuring Quality of Decisions About Treatment of Menopausal Symptoms
NCT01152294
Tobacco Dependence Treatment for Asian Americans
NCT01091363
Pediatric Behavioral Informatics to Prevent Cancer
NCT01768533
RCT of an Acceptance-based Behavior Therapy for GAD
NCT00961493
Acceptance-Based Treatment for Generalized Anxiety Disorder
NCT00073632
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Therapeutic Areas
What is open in the University of Massachusetts, Boston pipeline
4 recruiting of 18 indexed (22% open); 14 completed (78%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Healthy (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Massachusetts, Boston: open-pipeline peers nationwide
Peers matched on 18 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Massachusetts, Boston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 trials (± recruiting share)
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors near 22% open enrollment (± trial volume)
- ALX Oncology · 22% recruiting · 9 trials
- Biosense Webster · 22% recruiting · 18 trials
- Englewood Hospital and Medical Center · 22% recruiting · 18 trials
- Ensysce Biosciences · 22% recruiting · 9 trials
Related
What to do with this University of Massachusetts, Boston page
18 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Boston or any single study.
- 4 of University of Massachusetts, Boston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Massachusetts, Boston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Massachusetts, Boston pipeline card: 18 registered trials from official public datasets.Report a data error.